The Effects of Limb Perfusion with Tumor Necrosis Factor on Circulating Levels of Proinflammatory Cytokines

Journal of Immunotherapy

Volumn 24, Issue 4, 2001, Pages 285-286

  Alexander, H Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MELPHALAN; TUMOR NECROSIS FACTOR;

CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; EUROPE; HEMODYNAMICS; HUMAN; KIDNEY PERFUSION; LIMB PERFUSION; LUNG PERFUSION; LUNG TOXICITY; MELANOMA; NOTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CYTOKINES; EXTREMITIES; HUMANS; MONITORING, INTRAOPERATIVE; SARCOMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034840149     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-200107000-00003     Document Type: Editorial

References (9)

1. Barker WC, Andrich MP, Alexander HR, Fraker DL. Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs. Eur J Nucl Med 1995; 22: 1242-8.
2. Hoekstra HJ, Naujocks T, Schraffordt-Koops H, et al. Continuous leaking monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results. Reg Cancer Treat 1992; 4: 301-4.
3. Alexander C, Omlor G, Berberich R, Gross G, Feifel G. Rapid measurement of blood leakage during regional chemotherapy. Eur J Nucl Med 1993; 4: 606-12.
4. Thom A K, Alexander HR, Andrich MP, Barker WC, Rosenberg SA, Fraker DL. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion (ILP) with high-dose TNF, interferon-gamma and melphalan. J Clin Oncol 1995; 13: 264-73.
5. Bartlett DL, Libutti SK, Figg WD, Fraker DL, Alexander HR. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001; 129: 176-87.
6. Klaase JM, Kroon BBR, van Geel AN, Eggermont AMM, Franklin HR. Systemic leakage during isolated limb perfusion for melanoma. Br J Surg 1993; 80: 1124-6.
7. Sorkin P, Abu-Abid S, Lev D, et al. Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment. Arch Surg 1995; 130: 1079-84.
8. Lans TE, Bartlett DL, Libutti SK, et al. Role of tumor necrosis factor (TNF) on toxicity and cytokine production after isolated hepatic perfusion (IHP). Clin Cancer Res 2001; 7: 784-90.
9. Alexander Jr. HR, 2001. Isolation perfusion. In: De Vita Jr, VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins, 2001, 769-76.